The FDA announced the enforcement discretion policy with respect regulation of FMT. This policy allows physicians use of FMT in treatment of C. difficile infections that do not respond to standard therapies without federal regulatory oversight.
The FDA announced the enforcement discretion policy with respect regulation of FMT. This policy allows physicians use of FMT in treatment of C. difficile infections that do not respond to standard therapies without federal regulatory oversight.